GLMD icon

Galmed Pharmaceuticals

17 hedge funds and large institutions have $2.47M invested in Galmed Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 5 closing their positions.

Holders
17
Holders Change
-1
Holders Change %
-5.56%
% of All Funds
0.45%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
2
Reduced
2
Closed
5
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
PWAM
1
Park West Asset Management
California
$923K 205,500
6CM
2
683 Capital Management
New York
$779K 173,516 -91,084 -34%
KCM
3
Knoll Capital Management
Florida
$224K 49,947 -15,053 -23%
SKK
4
Shepherd Kaplan Krochuk
Massachusetts
$144K 31,990
CAD
5
Craig A. Drill
$90K 20,000 +10,000 +100%
MC
6
Menta Capital
California
$81K 18,148 +800 +5%
CA
7
CapWealth Advisors
Tennessee
$54K 12,000
Renaissance Technologies
8
Renaissance Technologies
New York
$49K 10,900 +10,900 New
WJA
9
Williams Jones & Associates
New York
$45K 10,000 +10,000 New
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$23K 5,176
Deutsche Bank
11
Deutsche Bank
Germany
$23K 5,200 +5,200 New
Morgan Stanley
12
Morgan Stanley
New York
$22K 4,851
EDRE
13
Edmond de Rothschild (Europe)
Luxembourg
$4K 916
EDRH
14
Edmond de Rothschild Holding
Switzerland
$4K 916
Bank of America
15
Bank of America
North Carolina
$2K 460
RFA
16
Reilly Financial Advisors
California
$1K 250
TRCT
17
Tower Research Capital (TRC)
New York
$1K 308 +308 New
PA
18
Perceptive Advisors
New York
-75,000 Closed
DCM
19
DAFNA Capital Management
California
-13,488 Closed
Goldman Sachs
20
Goldman Sachs
New York
-11,831 Closed
Barclays
21
Barclays
United Kingdom
-2,380 Closed
UBS Group
22
UBS Group
Switzerland
-602 Closed